Company Filing History:
Years Active: 1988-1989
Title: Innovations in Pharmaceutical Formulations by Naohiro Ohishi
Introduction
Naohiro Ohishi, an accomplished inventor based in Fukuoka, Japan, has contributed significantly to the field of pharmaceuticals. With two notable patents to his name, his work focuses on innovative formulations aimed at treating gastrointestinal diseases. Collaborating with experts in the field, he is a valuable asset to the pharmaceutical industry.
Latest Patents
Ohishi's most recent patents illustrate his dedication to advancing drug formulations. The first patent involves pharmaceutical formulations of acid labile substances for oral use, which describes a preparation containing an acid labile compound in conjunction with an alkaline reacting compound. This formulation also includes layers of inert compounds and enteric coatings to ensure efficacy and patient comfort in treating gastrointestinal diseases.
His second patent focuses on a pharmaceutical preparation containing omeprazole, paired with an alkaline reacting compound. This preparation is similarly designed with multiple subcoating layers and an enteric coating, enhancing its effectiveness for oral administration in patients suffering from gastrointestinal ailments.
Career Highlights
Naohiro Ohishi is currently associated with Aktiebolaget Hassle, where he continues to innovate in pharmaceutical research and development. His contributions are instrumental in creating formulations that improve therapeutic outcomes for patients dealing with complex gastrointestinal conditions.
Collaborations
Throughout his career, Ohishi has worked with esteemed colleagues such as Kurt I Lovgren and Ake G Pilbrant. These collaborations bring together a wealth of knowledge and expertise, fostering an environment ripe for innovation in the pharmaceutical domain.
Conclusion
Naohiro Ohishi stands out as a dedicated inventor whose work is advancing the frontiers of pharmaceutical formulations. His contributions are vital for the development of effective treatments for gastrointestinal diseases, and his continued efforts in collaboration with skilled professionals promise further innovations in the field.